BY-HEALTH sets up research centre to focus on nutrition and anti-ageing solutions
BY-HEALTH and Shanghai Institute for Biological Sciences will jointly set up a research centre that studies nutrition and anti-ageing across the whole of China.
Shanghai Institute for Biological Sciences was founded in July 1999 by merging eight biological science institutes in Shanghai.
The move will see the company upgrade its technical capability in product innovation and expand cooperation between industry and the academia, BY-HEALTH said in an announcement.
‘Tackling obesity isn’t just about weight loss’: TargEDys develops probiotics to control appetite
French probiotic firm TargEDys is conducting an ongoing clinical trial to study the benefits of its probiotic strain on weight reduction in overweight subjects, as part of its ambition to help tackle the global obesity issue.
Historically, Asian regions had lower rates of obesity and overweight than US or Europe, however, with the high rates of economic growth, this is rapidly changing.
Speaking at our Probiota Asia event in Singapore, Dr Gregory Lambert, the firm’s CEO and VP of R&D, said: “Asians tend to have higher amounts of abdominal fat at lower BMIs and are more likely to develop central obesity, which is associated with higher risk of developing dyslipidaemia, impaired glucose tolerance, type 2 diabetes mellitus and CVD, as well as more adverse cardiovascular outcomes.”
Most important currency’: Local probiotic clinical studies key in driving BioGaia’s APAC growth
Clinical trials involving local population is “one of the most important currencies” for carving out a reputation amongst APAC’s healthcare practitioners, says Swedish probiotic firm BioGaia.
The firm’s regional manager and office head in APAC, Hok Ting Yau, made the comment when presenting the firm’s experience expanding into Asia, the challenges met, and the firm’s future strategies during our recent Probiota Asia Summit in Singapore.
He pointed out that having a local market presence would not suffice, as conducting local clinical studies was equally important, especially in winning over the industry’s KOL and healthcare practitioners.
New Blackmores CEO exclusive: India identified as a potential new market as firm looks to extend Asia reach
New Blackmores CEO Alastair Symington has told us the Australian supplement giant is weighing-up the option of market entry in India, while also preparing to unveil a new multi-channel strategy for China
Blackmores was one of several Australian firms to benefit from soaring China sales, both via e-commerce and daigou trade, between 2014-2017, but has struggled to maintain momentum in recent years.
In the firm’s annual report, published on Thursday, it was revealed that revenue in the China segment (key export accounts and in -country revenue) stood at $122m, down 15% on the prior year.
Black water: Indian firm launches ‘energy and metabolism-boosting’ alkaline mineral water
Black alkaline mineral water brand Evocus, which is said to produce energy and metabolism boosting effects, is expanding its presence across India’s supermarket chains and online space.
Launched by Indian health products firm A.V Organics in June, Evocus is available in nearly 200 supermarkets in Pune and Chandigarh, online and in the food service channel.
With a pH of about 8.5, the water contains more than 70 Humic and Fulvic trace minerals and is said to neutralise toxins and excessive acidity in the bloodstream, which leads to increased oxygen levels, improved energy and metabolism.
